10
Pediatric Grand Rounds 6/4/10 1 PEDIATRIC GRAND ROUNDS JUNE 4 TH , 2010 PEDIATRIC ECMO: OLD DOG OR NEW TRICK? Curt Froehlich, MD Pediatric ECMO Director CHRISTUS Santa Rosa ECMO Program Disclosures I have NO financial rela:onships with commercial interest to disclose I WILL be discussing off label use of FDA approved equipment I WILL BRIEFLY introduce equipment NOT FDA approved and will acknowledge when doing so Learning ObjecNves 1. Describe the basics of ECMO, basic contraindica:ons to ECMO, and the theory behind which ECMO can be used to treat disease. 2. Describe briefly the early applica:ons of ECMO on neonatal and adult pa:ents and how these pa:ent popula:ons have changed throughout the years. Learning ObjecNves 3. Describe the cost of ECMO as it compares to other therapies such as organ transplanta:on and bone marrow transplanta:on. 4. Describe briefly some of the future applica:ons of ECMO and its technologies including resuscita:on, transport, prematurity and organ transplanta:on and how these advances alter future pa:ent selec:on. Diseases desperate grown By desperate appliance are relieved, Or not at all. Claudius, King of Denmark In Hamlet Act IV Scene 3 W. Shakespeare Pediatric ECMO Borrowed from Jim Fortenberry, MD. Children's Healthcare of Atlanta at Egleston Desperate but Reasonable? Borrowed from Jim Fortenberry, MD. Children's Healthcare of Atlanta at Egleston

PEDIATRIC)GRAND)ROUNDS)JUNE)4TH,2010 …GRAND)ROUNDS)JUNE)4TH,2010) PEDIATRIC)ECMO:OLDDOG ORNEW)TRICK?) Curt)Froehlich,)MD) Pediatric)ECMO)Director) CHRISTUS)Santa)Rosa)ECMO)Program)

  • Upload
    lethu

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

Pediatric  Grand  Rounds  6/4/10  

1  

PEDIATRIC  GRAND  ROUNDS  JUNE  4TH,  2010  PEDIATRIC  ECMO:  OLD  DOG  

OR  NEW  TRICK?  Curt  Froehlich,  MD  Pediatric  ECMO  Director  

CHRISTUS  Santa  Rosa  ECMO  Program  

Disclosures  

•    I  have  NO  financial  rela:onships  with  commercial  interest  to  disclose  

•  I  WILL  be  discussing  off  label  use  of  FDA  approved  equipment  

•  I  WILL  BRIEFLY  introduce  equipment  NOT  FDA  approved  and  will  acknowledge  when  doing  so  

Learning  ObjecNves  

1.    Describe  the  basics  of  ECMO,  basic  contraindica:ons  to  ECMO,  and  the  theory  behind  which  ECMO  can  be  used  to  treat  disease.  

2.    Describe  briefly  the  early  applica:ons  of  ECMO  on  neonatal  and  adult  pa:ents  and  how  these  pa:ent  popula:ons  have  changed  throughout  the  years.  

Learning  ObjecNves  

3.    Describe  the  cost  of  ECMO  as  it  compares  to  other  therapies  such  as  organ  transplanta:on  and  bone  marrow  transplanta:on.  

4.    Describe  briefly  some  of  the  future  applica:ons  of  ECMO  and  its  technologies  including  resuscita:on,  transport,  prematurity  and  organ  transplanta:on  and  how  these  advances  alter  future  pa:ent  selec:on.  

Diseases  desperate  grown  By  desperate  appliance  are  relieved,  Or  not  at  all.  

-­‐Claudius,  King  of  Denmark  In  Hamlet  Act  IV  Scene  3  W.  Shakespeare  

Pediatric  ECMO  

Borrowed  from  Jim  Fortenberry,  MD.  Children's  Healthcare  of  Atlanta  at  Egleston    

Desperate  but  Reasonable?  

Borrowed  from  Jim  Fortenberry,  MD.  Children's  Healthcare  of  Atlanta  at  Egleston    

Pediatric  Grand  Rounds  6/4/10  

2  

Pediatric  ECMO  Outline  

•  History  •  Basic  Principles/Mechanics  

•  3  Types  of  ECMO  

– Respiratory  ECMO  

– Cardiac  ECMO  

– “Rescue”  ECMO  

Pediatric  ECMO  Outline  

•  Future  evolu:on  and  applica:ons  

•  “Cost”  of  ECMO  

•  CSRCH  ECMO  program  

•  Success  Story  

What  is  ECMO?  •  Stands  for:  Extra-­‐Corporeal  Membrane  Oxygena:on?  •  Should  it  stand  for  Extremely  Costly  Midnight  Opera:on?    • What  is  it?  – A  way  in  which  the  lungs  or  the  heart  and  lungs  can  be  ar:ficially  supported  for  prolonged  periods  of  :me  

ECMO  History  •  Technology  is  not  “new”    •  Reports  of  first  pa:ents  supported    in  1972  

•  First  Study  1972  in  Adults:  – Lots  of  new  centers  performing  ECMO  

– Showed  no  benefit  – ConvenNonal  therapy  beRer  than  Bad  ECMO!  

ECMO  History  •  Bartled  et  al,  Esperanza  first  neonatal  case  1976  

•  Bartled  et  al  1982  45  newborns,  90%  predicted  mortality  >50%  survival  

•  O’Rourke  1989  randomized  neonatal  trial:  Stopped  early  due  to  ECMO  benefit  

ECMO  Mechanics  

Pediatric  Grand  Rounds  6/4/10  

3  

VA  

VV  

VVDL  

ECMO  Basics  •  ECMO  provides  support,  it  does  not  FIX  ANYTHING  DIRECTLY!  

•  Right  therapy/Right  :me  

•  ECMO  support  allows  :me  to  heal,  op:mizing  fluid  status  and  nutri:on,  restora:on  of  acid/base  status  and  normalizing  oxygen  delivery  

ECMO  Basics  

•  ECMO  should  be  considered  if  the  process  is:  

– Severe  – Acute  – Poten:ally  reversible  

ECMO  ContraindicaNons  

• ONLY  Absolute:  – Do  Not  Resuscitate?  

“RelaNve”  ContraindicaNons  – Past  Contraindica:ons  – Neurological  compromise  – “Recent”  surgery/trauma  

– “Recent”  neurosurgical  procedures  

– Acute  mul:-­‐organ  failure  – Chronic  organ  insufficiency  

– Chronic  respiratory  insufficiency  – Immunosuppression    

Pediatric  ECMO  •  “Limited”  evidence  – No  randomized  control  trial  in  pediatric  paNents  

•  “Badle”  between  benefit  and  risk    

Pediatric  Grand  Rounds  6/4/10  

4  

All  who  drink  of  this  treatment  recover  within  a  short  :me,  except  in  those  

who  do  not.  

Therefore,  it  fails  only  in  incurable  cases          -­‐Galen  

Borrowed  from  Jim  Fortenberry,  MD.  Children's  Healthcare  of  Atlanta  at  Egleston    

Problems  In  Study  of  ECMO  

•  Small  popula:ons  •  Omen  selec:ng  the  sickest  pa:ents-­‐nonresponders  

•  Loss  of  equipoise  before  demonstra:on  of  effect  

•  Difficul:es  in  RCTs-­‐hard  to  randomize  within  a  center  

•  “Can’t  we  use  the  machine?”  Borrowed  from  Jim  Fortenberry,  MD.  Children's  Healthcare  of  Atlanta  at  Egleston    

Neonatal  ECMO  

ELSO Registry, 2010.

Pediatric  ECMO  

ELSO Registry, 2010.

ELSO Registry, 2010.

Overall  PaNent  Outcomes  

ELSO Registry, 2010.

Pediatric  Grand  Rounds  6/4/10  

5  

3  Types  of  ECMO  

• Respiratory  ECMO  

• Cardiac  ECMO  

• “Rescue”  ECMO  

Pediatric  Respiratory  ECMO  

•  Remember:  – Acute  – Severe  – Poten:ally  reversible  

•  All  mechanical  ven:la:on  causes  acute  lung  injury  (pressure,  volume,  jet,  APRV,  HFOV)  

– Earlier  is  beRer!  (before  irreversible  lung  injury)  

Green  et  al  Crit  Care  Med  1996  

ECMO

ECMO

ECMO

ECMO

ECMO  SelecNon  Criteria  for  Pediatric  Respiratory  Failure  •  OI  >  40  unresponsive  to  maximal  ven:latory  and  medical  management.  

•  Sta:c  lung  compliance  <  0.5cc/kg/cmH2O.  •  P/F  ra:o  <  200.  •  Barotrauma:  persistent  air  leak  on  maximal  ven:lator  support.  

•  Hypercarbic  respiratory  failure:  uncorrectable  hypercarbia  with  pH  <  7.0  despite  maximal  medical  management.  

Children’s Healthcare of Atlanta ECMO Selection Guidelines.

Pediatric  Cases  by  Diagnosis   Pediatric  Cardiac  ECMO  IndicaNons  

•  Reversible  dysfunc:on  of  heart  and/or  lungs  – High  lactate,  hypotension,  low  sats,  low  urine  output  

–   Not  responding  to  “maximal”  support  

•  Irreversible  dysfunc:on-­‐  “bridge”  to  transplant  •  Failure  to  wean  from  bypass  

•  Resuscita:on  •  Past  Contraindica:ons  

Pediatric  Grand  Rounds  6/4/10  

6  

Cardiac  ECLS  by  Diagnosis    Under  16  years  

Cardiomyopathy/MyocardiNs  •  2  categories  of  non-­‐surgical  cardiac  failure  increasingly  supported  by  ECLS  

•  Review  of  15  pediatric  viral  myocardi:s  – Overall  survival  was  80%  – 60%  recovered  func:on  to  be  weaned  off  with  normal  follow  up  func:on  – Recovery  for  non-­‐surgical  paNent  may  occur  aber  prolonged  cardiac  support!  – Median  duraNon  of  cardiomyopathy  support  was  140  hrs!  

Duncan  et  al.  J  Thorac  Cardiovasc  Surg  2001;122:440–8.  

ECPR:  fastest  growing  group  for  ECMO  

ELSO Registry, 2010.

51%  

28%  

Why  E-­‐CPR?  •  Survival  to  DC  in  Pediatric  Code  blue  events  – 92%  for  Respiratory  – 43%  respiratory  to  cardiac  – Only  24%  for  cardiac  arrest!  

•  0  to  5%  survival  from  paNents  with  >30  min  CPR  

•  Is  there  something  beder?  •  Cardiac  arrest  comprises  25%  of  all  indicaNons  for  ECMO  in  pediatric  paNents  

Current  CPR  Guidelines  •  Coronary  Perfusion  Pressure  (CPP)  is  Key  to  successful  resuscita:on  

•  Importance  of  minimally  interrupted  high  quality  chest  compressions  – Push  hard!  – Push  fast!  

•  HypervenNlaNon  is  harmful!  

E-­‐CPR  •  AKA  Rapid  deployment  ECMO,  Resuscita:on  or  R-­‐ECMO,  Extracorporeal  Cardiopulmonary  Rus:ca:on  

•  Use  of  ECMO  from  failed  CPR  

•  Goal  of  cannula:on  in  30  min  or  less  

•  Limited  to  witnessed  inpa:ent  arrest  (ICU,  cath  lab,  floor)  

•  Required  a  tremendous  amount  or  resources  and  high  state  of  readiness  (Children’s  Hospital?)  

Pediatric  Grand  Rounds  6/4/10  

7  

E-­‐CPR  •  Surgical  availability  – Level  I  trauma  center?  

•  Pre-­‐primed  circuit  

– ECMO  specialist  able  to  prime  24  hrs/day  on  site  

•  Blood  bank  •  ICU  physician,  nursing  staff  •  Early  ECMO  considera:on  and  ini:a:on  

– <5  min  into  CPR  

ECPR:  beRer  than  convenNonal  CPR  

Morris, Pediatr Crit Care Med, 2004.

E-­‐CPR  •  What  about  neurologic  status?  •  VTACH  in  a  4  YO  with  myocardi:s  – 176  minutes  CPR  – 9  days  ECMO  – DC’ed  home  normal  

•  Morris  study  from  CHOP  with  3  of  6  survivors  with  >60  min  CPR:  Neurologically  normal!  

•  Acceptable  dura:on  of  CPR?  – Quality  not  quanNty!  

“Atypical”  ECMO  uses  •  Post-­‐trauma:c  respiratory  failure  – bleeding  from  trauma  injuries  is  “manageable”  

•  Burns  – culture  posi:ve  pa:ents  with  43%  ECMO  survival  

•  Immunosuppressed  – higher  risk  of  infec:on  – pa:ents  with  wbc  <  1.5  with  32%  survival    

•  Sepsis  – Direct  cardiac  cannula:on?  

The  “Future”  of  Pediatric  ECMO  

Slide  Courtesy  of  Robert  Bartled   Slide  Courtesy  of  Robert  Bartled  

Pediatric  Grand  Rounds  6/4/10  

8  

                       Ambulatory  Lung  Assist  with  PA-­‐LA  implantaNon  

5  weeks,  bridging  to  transplant          Regensberg,  2007  

AALA  bridge  to  XP:    Hoopes,  2009  

ECLS  Research:    ArNficial  Placenta    

Slide  Courtesy  of  Robert  Bartled  

What  about  Cost?  •  Financial  Obliga:on  /  Ins:tu:onal  Responsibili:es  (1993  analysis)  – Average  cost  of  ECMO  pa:ent:  $50,000  – Assuming  accepted  mortality  and  survival  rates  – Comparisons:  • Renal  Transplant  -­‐  $16,300/life  year  saved  • Heart  Transplant  -­‐  $26,900/life  year  saved  • Liver  Transplant  -­‐  43,500/life  year  saved  • Bone-­‐Marrow  Transplant  -­‐  $62,500/life  year  saved  Borrowed  from  Jim  Fortenberry,  MD.  Children's  Healthcare  of  Atlanta  at  Egleston    

ECLS  Can  Be  Cost-­‐EffecNve  

Vats  et  al.,  Crit    Care  Med  1998

Cost/Life-­‐year-­‐saved:  Pediatric  ECLS  vs.  Other  Therapies  

Pediatric  Grand  Rounds  6/4/10  

9  

CHRISTUS  Santa  Rosa  ECMO  Program  

•  Neonatal  Program  began  in  1989  – >100  pts  

•  In  2008  began  a  comprehensive  pediatric  program  in  conjunc:on  with  Wilford  Hall  

•  Last  year  CSRCH  supported  18  ECMO  pa:ents    

•  >100  ECMO  days  in  the  pediatric  ICU  last  year  

•  Program  con:nues  to  grow  

Recent  Success    9  month  old  female  with  MSSA  pneumonia/air  leak  cannulated  in  Temple  Texas  (150  miles  north  of  San  Antonio).    Transported  back  and  underwent  43  days  of  VA  ECMO,  including  air  leak  on  rest  sewngs      

Recent  Success  

Happy  Second  Birthday!  

Conclusions  •  Pediatric  ECMO  is  established  for  diseases  :  

– Severe  – Acute  – Poten:ally  reversible  

•  ECMO  has  evolved  from    neonates  to  all  age  groups  

•  Only  absolute  contraindica:on  is  a  DNR  – “Rela:ve”  contraindica:ons  

Pediatric  Grand  Rounds  6/4/10  

10  

Conclusions  •  ECMO  can  be  cost  effec:ve  

•  ECMO,  ECMO  equipment  and  applica:ons  of  ECMO  con:nue  to  evolve  

– Resuscita:on  – Transport  – “Bridge”  to  transplant      – Prematurity  

         Plenty  of  new  tricks!  

Hopefully  I  have  not  led  you  astray…  

Borrowed  from  Jim  Fortenberry,  MD.  Children's  Healthcare  of  Atlanta  at  Egleston    

But  remember!   With  great    thanks…  •  En:re  ECMO  team…  – Coordinators  – Primers  

– Specialists  •  CSRCH  Neonatal  Team  

•  UTHSCSA  Perfusion  Group  

•  Wilford  Hall  ECMO  Program  

•  Jim  Fortenberry  

•  Robert  Bartled  

With  great    thanks…   QuesNons?